Diagnosis and management of dementia with Lewy bodies2005· review· en· Neurology· Medicineaff5,057citations
Diagnosis and management of dementia with Lewy bodies2017· review· en· Neurology· Medicinefundno aff4,446citations
Clinical diagnostic criteria for dementia associated with Parkinson's disease2007· review· en· Movement Disorders· Medicineaff3,035citations
Vascular cognitive impairment2003· review· en· The Lancet Neurology· Medicineaffno abstract1,128citations
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review2019· review· en· Movement Disorders· Medicineaff987citations
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder2008· article· en· Neurology· Medicineafffund772citations
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction2023· review· en· Cell Death and Disease· Medicinefundno aff739citations
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study2011· article· en· The Lancet Neurology· Medicineaffno abstract629citations
REM sleep behaviour disorder2018· review· en· Nature Reviews Disease Primers· Neuroscienceaffno abstract487citations
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies2013· review· en· JAMA Neurology· Medicineafffund444citations
Parkinson risk in idiopathic REM sleep behavior disorder2015· article· en· Neurology· Medicineafffund432citations
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?2016· review· en· Journal of Parkinson s Disease· Medicineafffund425citations
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium2017· article· en· Newcastle University ePrints (Newcastle Univesity)· Neurosciencefundno aff379citations
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study2019· article· en· Brain· Medicineafffund378citations
Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases2006· review· en· The Lancet Neurology· Medicineafffundno abstract374citations
Sleep and quantitative EEG in neurodegenerative disorders2004· review· en· Journal of Psychosomatic Research· Medicineaffno abstract351citations
Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies2009· article· en· Acta Neuropathologica· Medicineaffno abstract346citations
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study2021· article· en· The Lancet Neurology· Medicinefundno affno abstract332citations
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy2011· article· en· Proceedings of the National Academy of Sciences· Medicineaff317citations
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study2012· article· en· Movement Disorders· Medicineafffund305citations
Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing2011· article· en· Annals of Neurology· Medicineaff305citations
α‐Synuclein oligomers and clinical implications for Parkinson disease2012· review· en· Annals of Neurology· Medicineafffund291citations
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study2015· article· en· Annals of Neurology· Medicineaff291citations
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study2017· article· en· The Lancet Neurology· Biochemistry, Genetics and Molecular Biologyafffundno abstract289citations